---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-017516"
form_type: "8-K"
ticker: "RKDA"
cik: "0001469443"
company_name: "Arcadia Biosciences, Inc."
filed_at: "2022-08-16T23:59:59+00:00"
generated_at: "2026-06-23T23:26:34.664072+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Arcadia Biosciences raises ~$5M via registered direct offering of common stock and warrants

## Summary
- Sold 4,722,506 shares at $1.05876 per share plus pre-funded warrants to an institutional investor.
- Issued investment options for 4,722,506 shares at $0.93376, exercisable immediately for 5 years.
- H.C. Wainwright earned a 6% cash fee (est. $300K) plus warrants for 236,125 shares at $1.3235.
- Closing occurred August 16, 2022; offering priced at-the-market under Nasdaq rules.

## SEC filing metadata
- accession: 0000950170-22-017516
- form_type: 8-K
- ticker: RKDA
- cik: 0001469443
- company_name: Arcadia Biosciences, Inc.
- filed_at: 2022-08-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1469443/000095017022017516/0000950170-22-017516-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1469443/000095017022017516/rkda-20220812.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-017516
- JSON: https://secwatch.observer/filing/0000950170-22-017516.json
- Plain text: https://secwatch.observer/filing/0000950170-22-017516.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.